Xijing Hospital, Xi'an, Shaanxi, China - 20 Jan `26Removing halo moles to study active vitiligo

Removing halo moles to study active vitiligo

Official title: Central Nevus Removal Versus Conservative Treatment for Halo Nevus With Vitiligo: A Prospective Randomized Controlled Trial

Status: Opening soon

Description:

Xijing Hospital plans to enroll about 60 participants. The study removes halo moles, which are surrounded by pale skin, to see whether they help drive immune activity in vitiligo. Researchers want to learn whether removal can help stabilize disease or improve response to standard treatment. Possible risks include pain, bleeding, infection, scarring, and pigment changes. People ages 6 to 45 may qualify. Recruitment has not started yet; the record lists one listed site in China.

Start date: January 20, 2026

Completion date: October 01, 2027

Organizer: Xijing Hospital

Contact: Zhe Jian

Tel.: 86 153 323 325 87

Email: xjzhejian@fmmu.edu.cn

Link: https://clinicaltrials.gov/study/NCT07307534

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Removing halo moles to study active vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions

  • Does halo nevi affect vitiligo development?

    Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...

  • Any link between vitiligo and military service?

    While there isn't specific research directly linking military service to the onset of vitiligo, it's critical to comprehend that vitiligo is a multifaceted disorder influenced b...

  • PTSD in Vitiligo?

    Living with vitiligo often involves more than managing visible skin changes. Many individuals face discrimination, social stigma, and feelings of isolation, leading to emotional...